Stay updated on Nivolumab Ipilimumab Local Consolidation Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab Local Consolidation Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab Local Consolidation Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedPrimary completion and study completion dates updated to 2027-03-31; the previous 2026-03-31 date has been removed. New March 2026 entries (2026-03-23 and 2026-03-20) were added to the study record.SummaryDifference0.3%

- Check18 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated to v3.4.3; the previous version v3.4.2 was removed.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page revision label changed from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check61 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page now displays a glossary option and includes updated metadata labels such as 'Last Update Submitted that Met QC Criteria' with a revision bump to v3.4.0, and capitalization changes for 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Nivolumab Ipilimumab Local Consolidation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Local Consolidation Clinical Trial page.